Home › Niet-kleincellige longkanker › Wisconsin › La Crosse
Niet-kleincellige longkanker klinische studies in La Crosse, WI
10 studies voor Niet-kleincellige longkanker zoeken deelnemers op locaties in en rond La Crosse (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- Gundersen Lutheran Medical Center, La Crosse
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruterenFase 3
- Gundersen Lutheran Medical Center, La Crosse
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RekruterenFase 2
- Gundersen Lutheran Medical Center, La Crosse
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RekruterenFase 2/3
- Gundersen Lutheran Medical Center, La Crosse
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruterenFase 2
- Gundersen Lutheran Medical Center, La Crosse
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Gundersen Lutheran Medical Center, La Crosse
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2/3
- Gundersen Lutheran Medical Center, La Crosse
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Gundersen Lutheran Medical Center, La Crosse
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- Gundersen Lutheran Medical Center, La Crosse
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
GEMINI-NSCLC: NSCLC Biomarker Study
RekruterenObservatieonderzoek
- Gundersen Health System, La Crosse
Niet-kleincellige longkanker studies in andere steden
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Andere studies in La Crosse
- Longkanker9 studies
- Borstkanker6 studies
- Acute myeloïde leukemie6 studies
- Multipel myeloom4 studies
- Diffuse groot-B-cel lymfoom3 studies
- Keelholtekanker3 studies
- Mondkanker3 studies
- Plaveiselcelcarcinoom van hoofd en hals3 studies
- Endometriumkanker3 studies
- Eierstokkanker3 studies
- Melanoom3 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.